VOLITIONRX LTD — Director's Dealing 2024

Sep 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2024-09-01-05:00

Reporting Person: Rootsaert Rodney Gerard (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-01-05:00	Common Stock	A	15258	—	Acquired	136594	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1007718	Indirect

Footnotes

F1: On September 1, 2024, the reporting person was awarded 15,258 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three equal installments of 5,086 units on each of September 1, 2024, October 1, 2024 and November 1, 2024, respectively, are also subject to further time-based vesting in a single installment on June 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.

F2: The shares of common stock are held directly by Concord International, Inc. The reporting person is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc.